ArticlePloS one2026
Fatty acid and melatonin-enriched warming: A novel approach using vitrified oocytes and early-stage embryos for patients with poor prognosis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCryopreservation and warming can induce cellular stress that impairs oocyte and embryo competence, particularly in poor-prognosis patients. Although fatty acids and melatonin have been proposed to support cytoskeletal stability and reduce oxidative stress, their combined use during warming has not been specifically evaluated. This study evaluated whether co-supplementation with fatty acids and melatonin during warming improves embryological development and clinical outcomes following thawing of vitrified oocytes or early-stage embryos.
methodsThis retrospective cohort study was conducted at a single fertility centre between August 2022 and December 2024. The embryo-thawed cohort comprised women aged ≥35 years with poor embryo quality, defined as failure to achieve blastocyst cryopreservation in at least two prior in vitro fertilisation cycles. The oocyte-thawed cohort included women aged ≥35 years at vitrification. Warming was performed with or without 1% fatty acids and 10 µM melatonin. Embryological and clinical outcomes were compared using non-parametric analyses, with age-adjusted comparisons by multivariable regression.
resultsIn the oocyte-thawed cohort, warming with fatty acids and melatonin significantly improved oocyte survival (91.4% vs. 76.7%), spindle alignment (71.2% vs. 55.1%), and embryo development, with higher good-quality cleavage (51.0% vs. 24.1%) and blastocyst formation rates (24.6% vs. 10.3%) (all P < 0.001). Clinical pregnancy was also higher in the supplemented group (38.5% vs. 16.1%; adjusted OR 3.21; 95% CI, 1.17-8.82; P = 0.024). In the embryo-thawed cohort, enriched warming increased blastocyst formation (41.4% vs. 29.3%; P = 0.024), high-quality blastocyst rate (51.1% vs. 27.3%; P < 0.001), implantation (26.1% vs. 14.4%; P = 0.002), and clinical pregnancy (51.4% vs. 29.1%; adjusted OR 3.13; 95% CI, 1.75-5.60; P < 0.001).
conclusionsCo-supplementation with fatty acids and melatonin during warming improved oocyte survival, spindle alignment, embryo development, and clinical pregnancy outcomes in poor-prognosis patients. This simple, clinically applicable approach may reduce cryo-induced stress and enhance reproductive success.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.